Obalon Therapeutics Inc.

NASDAQ: OBLN · Real-Time Price · USD
3.05
-0.19 (-5.86%)
At close: Jun 16, 2021, 6:00 AM

Obalon Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2021 Q1 2021
Period Ending Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
40.16M 8.97M
Short-Term Investments
n/a n/a
Long-Term Investments
n/a n/a
Other Long-Term Assets
-52.77M 3.24M
Receivables
3.42M 3.15M
Inventory
2.89M n/a
Other Current Assets
19.13M 672K
Total Current Assets
65.61M 12.79M
Property-Plant & Equipment
2.22M 1.31M
Goodwill & Intangibles
50.55M n/a
Total Long-Term Assets
52.77M 4.55M
Total Assets
120M 17.34M
Account Payables
3.1M 582K
Deferred Revenue
n/a n/a
Short-Term Debt
1.33M 430K
Other Current Liabilities
56.07M 5.85M
Total Current Liabilities
60.5M 6.86M
Long-Term Debt
n/a -120K
Other Long-Term Liabilities
770K 502K
Total Long-Term Liabilities
1.39M 382K
Total Liabilities
61.88M 7.25M
Total Debt
664K 310K
Common Stock
8K 10K
Retained Earnings
n/a -188.93M
Comprehensive Income
-109K n/a
Shareholders Equity
58.12M 10.1M
Total Investments
n/a n/a